It is known that 5–10% of BC cases have a hereditary component [2], being characterized by the presence of germline mutations in the BRCA1 [3] or BRCA2 [4] genes, which are associated with the hereditary breast and ovarian cancer predisposition syndrome (HBOC). This evidence concerns the gene BRCA2 and breast cancer.